Article
Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging.
Molecular psychiatry - 1 Jan 2021
Yan Qi, Nho Kwangsik, Del-Aguila Jorge L, Wang Xingbin, Risacher Shannon L, Fan Kang-Hsien, Snitz Beth E, Aizenstein Howard J, Mathis Chester A, Lopez Oscar L, Demirci F Yesim, Feingold Eleanor, Klunk William E, Saykin Andrew J, Cruchaga Carlos, Kamboh M Ilyas
Abstract excerpt
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
